Enovis Corp <ENOV.N>: UBS Assumes Coverage With Buy Rating; Price Target $51 vs $50
ENOV•Related News
Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder
CMND•
Textron tops quarterly results estimates on higher aircraft pricing
TXT•
Core Scientific signs AI infrastructure deal with AMD
CORZ•
Kazia Therapeutics files provisional patent for strategy to prevent metastatic recurrence in triple-negative breast cancer
KZIA•
BetMGM cuts outlook as prediction market competition grows
MGM•